SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biogen
BIIB 186.00-0.5%Jan 8 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: KENNETH R SANDERS who wrote (892)3/2/1999 10:04:00 AM
From: William Partmann   of 1686
 
Biogen Inc. (BGEN) 104 1/16 +1 13/16: --UPDATE-- US Bancorp Piper Jaffray reiterates "buy" rating on biopharmaceutical company as FDA upholds Avonex's marketing exclusivity under orphan drug act; although decision was expected, FDA's decision renews confidence in Avonex's competitive position and sales prospects; raises price target from $90 to $105 a share.....
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News